Praxis Precision Medicines (PRAX) Treasury Shares (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Treasury Shares of $131802.0 for Q1 2026, down 74.76% year-over-year from $522257.0 in Q1 2025, and down 74.46% quarter-over-quarter from $516119.0 in Q3 2025.
Praxis Precision Medicines (PRAX) Treasury Shares (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Treasury Shares history runs 8 years deep, the most recent figure standing at $131802.0 for Q1 2026.
- In Q1 2026, Treasury Shares fell 74.76% year-over-year to $131802.0; the TTM figure through Mar 2026 stood at $131802.0 (down 74.76% YoY), while the FY2024 annual figure was $224473.0, up 376.13% from the prior year.
- Treasury Shares for Q1 2026 stood at $131802.0, down from $516119.0 in the prior quarter.
- The five-year high for Treasury Shares was $856287.0 in Q2 2022, with the low at $47145.0 in Q4 2023.
- The 5-year median for Treasury Shares is $515857.5 (2025), against an average of $435025.8.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares tumbled 88.74% in 2022, then jumped 435.09% in 2025.
- Praxis Precision Medicines' Treasury Shares stood at $49565.0 in 2022, then fell by 4.88% to $47145.0 in 2023, then surged by 376.13% to $224473.0 in 2024, then soared by 129.92% to $516119.0 in 2025, then plunged by 74.46% to $131802.0 in 2026.
- Business Quant data shows PRAX's Treasury Shares at $131802.0 in Q1 2026, $516119.0 in Q3 2025, and $515596.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.10 Bn | 131.24 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.66 Bn | 76.67 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.59 Bn | 59.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.02 Bn | 54.88 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.64 Bn | 36.55 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.90 Bn | 28.59 Bn | 992.69 Mn | - |
| 7 | Royalty Pharma | 27.38 Bn | 26.55 Bn | - | 2.72 Mn |
| 8 | BioNTech SE | 27.36 Bn | 8.97 Bn | 668.28 Mn | 8.96 Mn |
| 9 | Insmed | 26.66 Bn | 25.50 Bn | 358.27 Mn | - |
| 10 | Praxis Precision Medicines | 10.86 Bn | 10.10 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 522,990.00 |
| Jun 30, 2026 | 522,990.00 |
| Mar 31, 2026 | 131,802.00 |
| Mar 31, 2026 | 131,802.00 |
| Sep 30, 2025 | 516,119.00 |
| Sep 30, 2025 | 516,119.00 |
| Jun 30, 2025 | 515,596.00 |
| Jun 30, 2025 | 515,596.00 |
| Mar 31, 2025 | 522,257.00 |
| Mar 31, 2025 | 522,257.00 |
| Dec 31, 2024 | 224,473.00 |
| Dec 31, 2024 | 224,473.00 |
| Sep 30, 2024 | 222,674.00 |
| Sep 30, 2024 | 222,674.00 |
| Jun 30, 2024 | 101,462.00 |
| Jun 30, 2024 | 101,462.00 |
| Mar 31, 2024 | 97,601.00 |
| Mar 31, 2024 | 97,601.00 |
| Dec 31, 2023 | 47,145.00 |
| Dec 31, 2023 | 47,145.00 |